According to recent publications, during the pathogenesis of diabetes, MT-ND4 has a quite low-expression pattern and on the contrary, MT-ND5 has a relevantly higher expression level, corresponding with the prediction expression level of their agonists individually (Elango et al., 2014; Urbanova et al., 2017). Here, MT-ND4 is linked to diabetes mellitus.